DR. SAMUEL FORRESTER HUNTER, M.D., PH.D.
Radiology at Forrest Crossing Blvd, Franklin, TN
License number
Tennessee 29410
Category
Neurology
Type
Neurology
License number
Tennessee 29410
Category
Neurology
Type
Clinical Neurophysiology
License number
Tennessee 29410
Category
Radiology
Type
Neuroradiology
Address
Address
101 Forrest Crossing Blvd SUITE 103, Franklin, TN 37064
Phone
(615) 791-5470
(615) 595-0265 (Fax)
(615) 595-0265 (Fax)
Professional information
Dr. Samuel F Hunter, Franklin TN - MD (Doctor of Medicine)
Specialties:
Neurology, Diagnostic Neuroradiology, Neuropsychiatry (Neurology)
Address:
Advanced Neuroscience Institute
101 Forrest Crossing Blvd STE 103, Franklin 37064
(615) 791-5470 (Phone)
101 Forrest Crossing Blvd STE 103, Franklin 37064
(615) 791-5470 (Phone)
Procedures:
Botox (Spasticity), Botox For Migraine Treatment, Electromyogram (Emg), Evoked Potential Test, Mri (Magnetic Resonance Imaging), Nerve Conduction Studies, Therapeutic Botox Injections
Conditions:
Alzheimer's Disease, Bell's Palsy, Carpal Tunnel Syndrome, Cervical Dystonia, Chronic Myeloid Leukemia (Cml), Dementia, Dizziness, Dysautonomia, Epilepsy and Seizures, Headache-Free Migraine, Hyperhidrosis (Excessive Sweating), Infusion Therapy, Multiple Sclerosis (Ms), Myasthenia Gravis, Neuromyelitis Optica, Neuropathy, Optic Neuritis, Parkinson's Disease, Spasticity, Stroke, Transverse Myelitis
Certifications:
Neurology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English, Finnish
Hospitals:
Advanced Neuroscience Institute
101 Forrest Crossing Blvd STE 103, Franklin 37064
Saint Thomas West Hospital
PO Box 380, Nashville 37205
Williamson Medical Center
4321 Carothers Pkwy, Franklin 37067
101 Forrest Crossing Blvd STE 103, Franklin 37064
Saint Thomas West Hospital
PO Box 380, Nashville 37205
Williamson Medical Center
4321 Carothers Pkwy, Franklin 37067
Philosophy:
We provide cutting edge neurological care in imaging and subspecialty neurology, and provide access to comprehensive care for multiple sclerosis and related conditions. Our imaging program provides a more thorough evaluation than can be obtained in most centers. We also provide numerous opportunities for patients to receive medications through a large clinical research program.
Education:
Medical School
University Of Texas Medical Branch At Galveston
Graduated: 1991
Mayo Clinic
Graduated: 1992
Mayo Grad School Med/Mayo Fndn
Graduated: 1995
Graduated: 1997
Oral Roberts U
Graduated: 1983
Fulbright Scholar University Of Helsinki
Graduated: 1984
University Of Texas Medical Branch At Galveston
Graduated: 1991
Mayo Clinic
Graduated: 1992
Mayo Grad School Med/Mayo Fndn
Graduated: 1995
Graduated: 1997
Oral Roberts U
Graduated: 1983
Fulbright Scholar University Of Helsinki
Graduated: 1984
Samuel Forrester Hunter, Franklin TN
Specialties:
Neurologist
Address:
101 Forrest Crossing Blvd, Franklin, TN 37064
Education:
University of Texas Medical Branch, School of Medicine - Doctor of Medicine
University of Texas Medical Branch - Doctor of Philosophy
The Mayo Clinic - Fellowship - Neurology
The Mayo Clinic - Residency - Neurology
The Mayo Clinic - Internship - Internal Medicine
University of Texas Medical Branch - Doctor of Philosophy
The Mayo Clinic - Fellowship - Neurology
The Mayo Clinic - Residency - Neurology
The Mayo Clinic - Internship - Internal Medicine
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Method For Treatment Of Demyelinating Central Nervous System Disease
US Patent:
2004014, Jul 22, 2004
Filed:
Oct 16, 2003
Appl. No.:
10/687576
Inventors:
Samuel Hunter - Franklin TN, US
International Classification:
A61K048/00, A61K038/19
US Classification:
424/085100, 514/044000
Abstract:
A method for treating demyelinating central nervous system diseases in a subject that comprises administering to the subject a composition comprising a therapeutically active amount of colony stimulating factor or CSF-like ligand. In a preferred embodiment of the present invention, the CSF is a GM-CSF. In a most preferred embodiment of the present invention, CSF is sargramostim.
Method For Treatment Of Demyelinating Central Nervous System Disease
US Patent:
7732407, Jun 8, 2010
Filed:
Aug 24, 2006
Appl. No.:
11/467088
Inventors:
Samuel F. Hunter - Franklin TN, US
International Classification:
A61K 38/19, C07K 14/535
US Classification:
514 12
Abstract:
A method for treating demyelinating central nervous system diseases in a subject that comprises administering to the subject a composition comprising a therapeutically active amount of colony stimulating factor or CSF-like ligand. In a preferred embodiment of the present invention, the CSF is a GM-CSF. In a most preferred embodiment of the present invention, CSF is sargramostim.